Researchers may have hit "gold" when it comes to the treatment of multiple sclerosis. An experimental medication called CNM-Au8 — a drinkable liquid with gold nanocrystals — has shown ...

First Quarter 2024 and Recent Operating Highlights CNM-Au8 for the treatment of MS In April, the Company announced at the 2024 American Academy of Neurology (AAN) Annual Meeting clinical data ...

April 30, 2024 – People with multiple sclerosis who drank a medicine containing gold nanocrystals daily for nearly 3 years got better vision. Vision problems are a nearly universal symptom of ...

CNM-Au8 is crafted to act as an energy stabilizer within the brain. Despite their gold composition, these nanoparticles ...

Cars.com is a leading digital marketplace and solutions provider for the automotive industry that connects car shoppers with sellers. Launched in 1998 and headquartered in Chicago, the Company ...

Opens in a new tab or window DENVER -- An oral suspension of clean-surfaced gold nanocrystals known as CNM-Au8 was safe and well-tolerated in patients with stable relapsing-remitting multiple ...

Following the conclusion of the double-blind period of the trial, participants were given the opportunity to continue with CNM-Au8® treatment at a dose of 30mg for an additional 96 weeks during ...

“Etherington highlighted the key finding that long-term CNM-Au8 treatment showcased improvements in vision, as measured by low contrast visual acuity, an essential assessment of visual function ...

CNM-Au8 is an oral suspension with demonstrated activity in restoring neuronal health and function by increasing energy production and utilization Treatment with CNM-Au8 investigated in clinical ...

An experimental medication called CNM-Au8 — a drinkable liquid with gold nanocrystals — has shown promising results in clinical trials in terms of improvements in MS symptoms. The ...